SRSF2 plays an unexpected role as reader of m(5)C on mRNA, linking epitranscriptomics to cancer Journal Article


Authors: Ma, H. L.; Bizet, M.; Soares Da Costa, C.; Murisier, F.; de Bony, E. J.; Wang, M. K.; Yoshimi, A.; Lin, K. T.; Riching, K. M.; Wang, X.; Beckman, J. I.; Arya, S.; Droin, N.; Calonne, E.; Hassabi, B.; Zhang, Q. Y.; Li, A.; Putmans, P.; Malbec, L.; Hubert, C.; Lan, J.; Mies, F.; Yang, Y.; Solary, E.; Daniels, D. L.; Gupta, Y. K.; Deplus, R.; Abdel-Wahab, O.; Yang, Y. G.; Fuks, F.
Article Title: SRSF2 plays an unexpected role as reader of m(5)C on mRNA, linking epitranscriptomics to cancer
Abstract: A common mRNA modification is 5-methylcytosine (m5C), whose role in gene-transcript processing and cancer remains unclear. Here, we identify serine/arginine-rich splicing factor 2 (SRSF2) as a reader of m5C and impaired SRSF2 m5C binding as a potential contributor to leukemogenesis. Structurally, we identify residues involved in m5C recognition and the impact of the prevalent leukemia-associated mutation SRSF2P95H. We show that SRSF2 binding and m5C colocalize within transcripts. Furthermore, knocking down the m5C writer NSUN2 decreases mRNA m5C, reduces SRSF2 binding, and alters RNA splicing. We also show that the SRSF2P95H mutation impairs the ability of the protein to read m5C-marked mRNA, notably reducing its binding to key leukemia-related transcripts in leukemic cells. In leukemia patients, low NSUN2 expression leads to mRNA m5C hypomethylation and, combined with SRSF2P95H, predicts poor outcomes. Altogether, we highlight an unrecognized mechanistic link between epitranscriptomics and a key oncogenesis driver. © 2023 Elsevier Inc.
Keywords: leukemia; genetics; neoplasm; neoplasms; rna binding protein; rna-binding proteins; myelodysplastic syndrome; messenger rna; rna, messenger; rna splicing; myelodysplastic syndromes; rna methylation; rna modification; cancer; humans; human; srsf2; serine arginine rich splicing factor; serine-arginine splicing factors; epitranscriptomics; m<sup>5</sup>c; nsun2; srsf2<sup>p95h</sup>; srsf2 protein, human
Journal Title: Molecular Cell
Volume: 83
Issue: 23
ISSN: 1097-2765
Publisher: Cell Press  
Date Published: 2023-12-07
Start Page: 4239
End Page: 4254.e10
Language: English
DOI: 10.1016/j.molcel.2023.11.003
PUBMED: 38065062
PROVIDER: scopus
PMCID: PMC11090011
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Akihide   Yoshimi
    35 Yoshimi